Skip to main content
Premium Trial:

Request an Annual Quote

Bayer Expands Research Facilities as Result of Millennium, Lion Links

Premium

W

OODBRIDGE, Conn.--Bayer said it has begun expanding its research facilities as a direct result of alliances with Millennium Pharmaceuticals and Lion Bioscience, which have given the pharmaceutical company access to genomic and bioinformatics-based research technologies. Bayer expects to spend $80 million to expand its research facilities in West Haven and Orange. Plans include construction of a chemistry research building and a high-throughput screening center. The company expects to hire more than 200 additional chemists and biologists by 2003.

Filed under

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.